Hennion & Walsh Asset Management’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-17,312
Closed -$302K 888
2024
Q2
$302K Buy
17,312
+77
+0.4% +$1.29K 0.02% 723
2024
Q1
$291K Buy
17,235
+78
+0.5% +$1.33K 0.02% 700
2023
Q4
$284K Buy
17,157
+85
+0.5% +$1.31K 0.02% 694
2023
Q3
$265K Buy
17,072
+94
+0.6% +$1.57K 0.02% 679
2023
Q2
$289K Sell
16,978
-453
-3% -$7.85K 0.02% 658
2023
Q1
$308K Sell
17,431
-357
-2% -$6.49K 0.02% 635
2022
Q4
$320K Buy
+17,788
New +$330K 0.02% 606

Other funds holding HQH

Hennion & Walsh Asset Management's HQH Position: Q3 2024 in Review

Hennion & Walsh Asset Management sold out of abrdn Healthcare Investors (HQH) in Q3 2024, closing a stake of 17,312 shares — an estimated $302K sold.

Hennion & Walsh Asset Management first reported a position in HQH in Q4 2022 and held it in 7 quarters. The position peaked at $320K in Q4 2022. 122 funds tracked by Wall St. Rank hold HQH as of Q3 2024.

  • Hennion & Walsh Asset Management reported no remaining abrdn Healthcare Investors position as of Q3 2024 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 17,312 abrdn Healthcare Investors shares in Q3 2024, an estimated $302K.
  • Hennion & Walsh Asset Management first reported a position in abrdn Healthcare Investors in Q4 2022 and held it in 7 quarters.
  • Hennion & Walsh Asset Management's abrdn Healthcare Investors position peaked at $320K in Q4 2022.
  • 122 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q3 2024.

Based on Hennion & Walsh Asset Management's 13F filing for Q3 2024, filed 22 Oct 2024.